Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
Nuevocor Raises $45 Million in Series B Funding Round
The funds will support a Phase I/II trial of its gene therapy candidate in an aggressive form of dilated cardiomyopathy due to LMNA gene mutations.
New Preclinical Testing Tools Help Researchers Tailor Treatment but Can They Fully Replace Mice?
Premium
Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, while others remain skeptical.
Haya Therapeutics Raises $65M in Series A Funds to Develop Noncoding RNA-Targeted Drugs
The firm develops RNA-guided therapeutics that target the regulatory genome, composed of genes that regulate expression of other genes.
BioCardia Kicks off New Phase III Trial of CardiAMP Heart Failure Cell Therapy
The firm enrolled the first patient at Florida's BayCare Morton Plant Hospital, and the study procedure went according to protocol, per an investigator.
Verve Advances Clinical Development Plans for Base-Editing Heart Disease Treatment
After VERVE-102 showed the ability to lower LDL-C and PCSK9 in the Heart-2 trial, the firm said it will advance the therapy to a Phase II study later this year.